Search

Články časopisu Can contraception to impact demographics dates?

Author of the article: Tomáš Fait Source: Praktická gynekologie | 4/2013 13. 12. 2013

News Doc. Petr Dulíček: Physical activity in hemophiliacs? Today it is a reality -⁠ just don't be afraid!

Thanks to modern treatment, the lives of hemophiliacs are becoming more active. Patients today can engage in most sports activities. On the contrary, avoiding physical activity carries the risk of developing other diseases. A doctor should support their patients so they are not afraid of physical activities and highlight their benefits, says the head of the Center for Hemostasis Disorders at the IV. Internal Hematology Clinic of LF UK and FN Hradec Králové, Doc. MUDr. Petr Dulíček, Ph.D., in an interview on hemophilia and sports.

Source: Hemophilia with Movement 30. 5. 2022

News Recommendations for Nutrition of Patients at Risk of or with Pressure Ulcers

Nutrition plays a crucial role in the prevention and treatment of pressure ulcers. In 2019, international recommendations for the nutrition of individuals at risk of or already with pressure ulcers were developed. Based on published evidence, they were prepared by expert groups PUAP/NPIAP/PPPIA (Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel, Pan Pacific Pressure Injury Alliance Prevention) as a clinical practice guide for doctors and nurses.

Source: Wound Healing 23. 8. 2021

News Incontinence Affects Mental Health –⁠ Actively Offer Help

Urinary incontinence is not a disease, but a symptom accompanying many illnesses. It is a very serious issue, which is also closely related to the quality of life and mental health of the patient. This is confirmed by the words of Austrian physician and co-founder of the field of neurourology Helmut Madersbacher: “Incontinence does not kill a person, but it kills their life.”

Source: Incontinence 3. 6. 2020

Články časopisu Use of PSA density and multiparametric MRI for indication of prostate biopsy

Author of the article: Miroslav Záleský, Jiří Stejskal, Vanda Adamcová, Jan Hrbáček, Ivo Minárik, Adam Pavličko, Jan Votrubová, Marek Babjuk, Roman Zachoval Source: Česká urologie | 1/2019 10. 4. 2019

News Updated Recommendations of the European Society of Cardiology for the Treatment of HCM

Newly published guidelines by the European Society of Cardiology (ESC) bring several updates in the care of patients with cardiomyopathies. In the following excerpt, we focus on new recommendations for the pharmacotherapy of hypertrophic cardiomyopathy (HCM) in the case of left ventricular outflow tract obstruction (LVOTO).

Source: Hypertrophic Cardiomyopathy (HCM) 28. 4. 2024

News The Patient Will Feel Comfortable Only with a Properly Chosen Absorption Aid

While before the approval of the amendment to the Public Health Insurance Act, it was possible to issue a prescription only for one type of aid firmly tied to a particular level of incontinence, now it is allowed to freely combine aids according to the individual needs of the patient. The modern market offers a wide range of aids −⁠ but how to choose a product that matches specific needs?

Source: Incontinence 27. 2. 2020

Články časopisu Recommendations for psychological assessment before bariatric surgery

Author of the article: Jitka Herlesová, Šárka Slabá, Dana Knappová, Pavel Král, Veronika Staňková, Martin Wagenknecht, Jana Žmolíková Source: Časopis lékařů českých | 3-4/2022 12. 9. 2022

Články časopisu Mycotic infections

Author of the article: MUDr. Matoušková Michaela Source: Urologické listy | 2/2005 2. 1. 2006

News Early Tumor Regression as a Marker of Overall Survival in First-Line Treatment of mCRC

In the treatment of metastatic colorectal cancer (mCRC), prognostic factors besides overall survival (OS) and progression-free survival (PFS) include early tumor regression (ETS) and depth of response (DpR). Japanese authors presented the results of an analysis at the European Society for Clinical Oncology (ESMO) congress in September 2022, which evaluated the correlation between ETS, DpR, and OS/PFS in patients with wild-type RAS mCRC from the PARADIGM study.

Source: Colorectal Cancer 21. 4. 2023

News Monitoring Limits in Prescribing Incontinence Aids is Essential

The amendment to the Public Health Insurance Act, which came into effect in December 2019, brought many changes in the reimbursement of medical aids through prescriptions. The methodology for determining the degree of incontinence has changed, and it is now also possible to combine aids according to the individual needs of the patient. We summarize other novelties related to limits issues in the following text.

Source: Incontinence 29. 2. 2020

News The Choice of Incontinence Aids Matters −⁠ But How Not to Get Lost Among Them?

Despite significant advances in medicine, a large number of patients still struggle with incontinence, which limits their comfort and reduces their quality of life. If treatment options have been exhausted, these patients rely on the use of incontinence aids, and therefore every urologist and general practitioner should be familiar with the current offerings and their applications.

Source: Incontinence 14. 4. 2020

News Alopecia Areata –⁠ Autoimmune Inflammatory Disease and a New Targeted Treatment Option

Alopecia areata (AA) is one of the non-scarring focal alopecias. It is an autoimmune disease of the hair follicle, the etiopathogenesis of which is not entirely understood. At the hair root, a lymphocytic inflammatory infiltrate develops, resulting in follicle miniaturization and the growth of a thin dystrophic hair. Recently, however, a new strategy for the treatment of AA has emerged, focusing on reducing inflammation of the hair follicle by inhibiting Janus kinases (JAK). This is the first therapeutic modality officially approved for this indication.

Source: Biological Treatment 31. 10. 2022

News Central European Expert Consensus on the Treatment of ITP in Adult Patients

In a recently published consensus, experts from Central Europe evaluate the current treatment options for immune thrombocytopenia (ITP) in adult patients and issue 7 recommendations for the administration of thrombopoietin receptor agonists (TPO-RA) in the 2nd line treatment of ITP, based on an analysis of 31 randomized controlled trials.

Source: Immune Thrombocytopenia 15. 4. 2024

News Current Indication Criteria for Testing Mutations in BRCA1 and BRCA2 Genes in Breast and Ovarian Cancer

Testing the mutation status of the BRCA1/2 genes can be beneficial for prevention, and in the case of already detected breast and/or ovarian cancer, also for direct treatment. We provide a brief overview of the current recommendations for testing based on the 2019 NCCN (National Comprehensive Cancer Network) guidelines and the recommended procedures of the Society of Medical Genetics ČLS JEP.

Source: Ovarian and Breast Cancer 16. 7. 2020